1
Registered trials
0
Recruiting
1
Unique sponsors
1
Unique IMPs
1
Commercial trials
Drug classes (ATC)
S
Ophthalmology/ENT (ATC S)
1
Mechanism of action (INN-stem analysis)
Beta-blocker
1 substance
Phase III:
1
Phase III
1 trial-
EndedBecro (Cyprus) Limited CommercialTIMOLOL MALEATE, BRIMONIDINE TARTRATE
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Becro (Cyprus) Limited | Commercial | 1 | Phase III | 0 |
New trials by year
2024
1